Confusion expected in wake of 'Right to Try' bill's signing

It's still entirely up to drugmakers whether they want to make their products available on an experimental basis. Patients may not see it that way.

from Most popular articles from Medical Marketing and Media https://ift.tt/2MBR5Cs